CreaGene to initiate phase 2 study for liver cancer vaccine

CreaGene Inc., an affiliated company of Choongwae Pharm, said on September 7 that it will conduct its local phase 2 clinical trials for CreaVax-HCC Inj. in five university hospitals, including Seoul National University Hospital and Samsung Medical Center.

For this study a total of 150 patients with liver cancer will be under treatment with Creavax-HCC Inj. for 30 months to evaluate the effic...